patient
Adventrx Pharma Sets Out to Improve Current Cancer Drugs
Douglas Cress submits: B y vanderson Chemotherapy drugs are powerful anti-cancer agents, but they can also cause adverse side effects such as rashes, nausea, and allergic reactions. Reformulating a popular drug offers pharmaceutical companies the opportunity to preserve a drug’s known strengths while reducing its weaknesses. Although reformulation can be a way for pharmaceutical companies to get more mileage out of a drug that’s about to go off-patent, it can benefit the patient as well
Should doctors use social media ?
Should physicians use social media for professional purposes ? That is a huge question that most health care professionals are going to have to answer. The first thing they need to determine is the objective for using social media.
Annual cost of non-compliance ? $163 billion
Three simple behaviors can achieve savings in healthcare.
Think you control your pharma brand ? Think again…
If you think you are in control of your brand just take a look at what has happened to Avandia; ▪ An unpublished study, which has not been peer reviewed or objectively scrutinized, states that using Avandia has led to the possibility of over 48,000 deaths by heart attack. ▪ The FDA is still evaluating the “data” for Avandia and has not specifically recommended if the drug is safe for patients. Now if you’re a physician who has prescribed Avandia and a patient comes to you and wants to know if it’s still safe to take what do you do
Read the full storyNow let’s attack free pharma samples because physicians shouldn’t give them to patients
According to an article in today’s WSJ; Shahram Ahari, a former Eli Lilly drug-sales representative, said samples helped him gain access and cement relationships with physicians. Mr. Ahari gave out samples of the depression medicine Prozac and schizophrenia treatment Zyprexa; he recalled having perhaps $200,000 worth of free medicines in his car and garage at any one point.
AMG 479 shows "promising activity" in pancratic cancer
Data from a
Immunocellular Therapeutics’ Brain Cancer Vaccine Extends Survival Rate in Small Trial
Douglas Cress submits: By vanderson A brain cancer vaccine from Immunocellular Therapeutics ( IMUC.OB ) has yielded positive results in a small Phase I clinical trial, reports Fierce Biotech. The study involved only 16 patients with glioblastoma multiforme, the most common form of brain cancer.
Wyeth Marketing Targeted Blacks Illegally: Lawsuit
A pair of former hospital sales reps filed a whistleblower suit alleging Wyeth, which is now owned by Pfizer, illegally promoted its Rapamune kidney transplant drug for use with other organs and targeted African-Americans, even though this is a high-risk patient group, according to the product labeling . The suit was filed by Marlene Sandler and Scott Paris in 2005, but was recently unsealed and an amended complaint was filed today ( see the suit )
Medication With Staying Power: A Look at Some Manufacturers
Douglas Cress submits: By vanderson Forgetfulness is one of the main barriers to medication compliance.
Liberalizing Regulations to Allow the Freer Flow of Information To Patients Globally – A Call for Harmonization
Is a patient in Europe different from a patient in the US?





